RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Stem Cell Promotor JVS-100 Appears Safe and Shows Promising Trends in HF after MI
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 12
SP 22
OP 23
DO 10.1177/155989771412014
UL http://mdc.sagepub.com/content/14/12/22.abstract
AB Patients with heart failure (HF) and previous myocardial infarctions (MIs) demonstrated favorable outcomes after treatment with JVS-100, a plasmid that encodes for stromal cell—derived factor-1. This article presents data from the Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure trial [STOP-HF; NCT01643590].